WinstonWınston
Stock

Safilo Group S.p.A.

0NJ5.L
62
Medical - Instruments & Supplies · Healthcare
Price
1.82 GBp
+0.01 (+0.69%)
Market Cap
£514.8M
Exchange
London Stock Exchange
Winston Score
62
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Oct 5, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Strong
21/30
Growth
Weak
3/20
Cash Flow
Exceptional
9/10
Stability
Exceptional
10/10
Valuation
Strong
8/10
Ownership
Good
10/15
Dividends
Weak
1/5

62 of 100 counted points = Winston Score 62.

Share count rising — dilution

+38.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 301.9M (2021) → 419.3M (2025)

§Winston Score History

The full picture

Safilo Group is an Italian company that designs and makes eyewear — things like glasses frames, sunglasses, and sports goggles. It sells its products through opticians, department stores, and online retailers around the world. Safilo is one of the largest eyewear manufacturers in Europe and makes products under its own brands, such as Carrera and Smith, as well as under licenses for fashion brands like Hugo Boss and Tommy Hilfiger.

The company earns money mainly by selling finished eyewear to wholesale customers, who then sell to consumers. Safilo operates globally, with most of its revenue coming from Europe and North America, and it manufactures in Italy, Slovenia, and China. Its licensed brand portfolio gives it access to well-known names, but those licenses must be regularly renewed, and losing a major one — as happened when Dior ended its agreement in 2020 — can meaningfully hurt revenue. Growing its own brands and reducing dependence on third-party licenses is the key strategic challenge going forward.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
67.2%
Premium pricing power — 67.2% gross margin
Profit after running costs
Operating Margin
12.1%
Healthy — 12.1% operating margin
Return on the money invested
ROCE
15.2%
Strong — 15.2% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
249%
Turns 249% of profit into real cash
Spare cash per sale
FCF Margin
12.4%
Converts sales into free cash efficiently (12.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.09
Conservative — low debt load (0.09)
Covers its interest
Interest Cover
100.00x
—
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
14.4x
Attractive valuation — P/E 14.4

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+3.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (14.4 → 11.4)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.25%
Small dividend — 0.25% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial